Ribosomal protein S6 pseudogene 4 (RPS6P4)

Ribosomal protein S6 pseudogene 4 (RPS6P4) is a processed pseudogene related to the ribosomal protein S6 gene family. Pseudogenes are non-functional copies of genes that typically arise from gene duplication or retrotransposition events; they are generally not translated into functional proteins and do not have known biological activity. While the protein-coding RPS6 gene is an important component of the ribosome with established roles in translation and cell proliferation[1][2][3], pseudogenes such as RPS6P4 do not contribute to these cellular processes. There is no evidence in current biomedical databases or literature to support RPS6P4 as a therapeutic target, biomarker, or molecular entity involved in disease, drug action, or biological function. The gene’s annotation as a pseudogene means it is not a typical target molecule. Additional context: - Pseudogenes like RPS6P4 are sometimes cataloged because their sequences can be detected in genomic studies, but they generally lack regulatory elements and open reading frames for producing functional proteins[3]. - Only the protein-coding ribosomal protein S6 (RPS6), not its pseudogenes, is implicated in processes like cell growth, translation, and has been studied in disease contexts (especially cancer)[2][3]. - There is no standard abbreviation or established alternative name for RPS6P4, aside from its systematic gene nomenclature. RPS6P4 is not a therapeutic target, biomarker, or functional protein-coding gene. Its inclusion in a target list is likely an error or artifact—use caution and consider removing it from analyses focused on actionable molecular targets.